Besides, association analyses of MALAT1 expression and patient's prognostic factors such as disease free survival and overall survival indicated that MALAT1 over-expression is correlated with poor prognosis in CRC patients, whereas multi-variate analysis confirmed MALAT1 as an independent prognostic risk factor. This evidence concerns the gene MALAT1 and colorectal carcinoma.